Prognosis of Primary Aldosteronism: A Prospective Cohort Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prognosis of Primary Aldosteronism: A Prospective Cohort Study — Stella

Home/Primary Aldosteronism/

View on ClinicalTrials.gov

Recruiting

Back to Primary Aldosteronism trials

Trial locations(2 sites)

China

The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang

Key details

Sponsor

Xinjiang Medical University

Collaborators

First Affiliated Hospital of Chengdu Medical College, First Affiliated Hospital of Xinjiang Medical University

Enrollment target

~5,000 participants

Started

January 2026

Primary completion

January 2031

Age range

18 Years – 80 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.